ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Community Cancer Center Defined

September 27, 1974

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei

May 22, 1992

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983